Soothe Versus Refresh
NCT00284999 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2006-08-22
Summary
To determine the ocular efficacy and safety of Soothe and Refresh Tears.
Conditions
- Dry Eye Syndromes
Interventions
- DRUG
-
Soothe
- DRUG
-
Refresh Tears
Sponsors & Collaborators
-
Pharmaceutical Research Network
lead OTHER
Principal Investigators
-
William C. Stewart, MD · Pharmaceutical Research Network, LLC
-
Penny Asbell, MD · Icahn School of Medicine at Mount Sinai
-
Christopher Chow, MD · Michigan Cornea Associates
-
Douglas G. Day, MD · Coastal Research Associates, LLC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2006-08-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
NCT05865379 ·Status: RECRUITING ·Phase: NA
-
Autologous Serum Eye Drops in Dry Eye Syndrome
NCT07295691 ·Status: RECRUITING ·Phase: NA
-
Effects of NOV03 on the Tear Film
NCT05723770 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms
NCT00535054 ·Status: COMPLETED ·Phase: NA
-
A Prospective Study of the Dry Eye Drink That Evaluates Hydration and Subject's Assessment on Eye Dryness
NCT05949697 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability
NCT03063489 ·Status: COMPLETED ·Phase: PHASE1
-
Symptom Response in Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Rohto® Hydra)
NCT02985827 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease
NCT01562795 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
NCT05660681 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
NCT01010282 ·Status: COMPLETED ·Phase: NA
-
A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
NCT01733992 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.
NCT02553772 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye
NCT04091581 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Ocular Comfort With ISTA Tears vs Systane
NCT01650584 ·Status: COMPLETED ·Phase: NA
-
Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms
NCT00938704 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
NCT05238597 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease
NCT03502447 ·Status: TERMINATED ·Phase: NA
-
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
NCT02974907 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry Eye
NCT01089985 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients
NCT05661851 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease
NCT05865457 ·Status: RECRUITING ·Phase: NA
-
Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease
NCT02435914 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
NCT04030962 ·Status: COMPLETED ·Phase: PHASE1/PHASE2